Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus

Sameer Joshi, Atul A. Chaudhari, Vida Dennis, Daniel J. Kirby, Yvonne Perrie, Shree Ram Singh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infection in infants and adults, effective treatment options remain limited. To circumvent this issue, there is a novel approach, namely, the development of multifunctional liposomes for the delivery of anti RSV-peptides. While most of the peptides that are used for loading with the particulate delivery systems are the penetrating peptides, an alternative approach is the development of liposome-peptide systems, which are loaded with an RSV fusion peptide (RF-482), which has been designed to inhibit the RSV fusion and block infection. The results of this work have revealed that the liposomes themselves can serve as potential RSV inhibitors, whilst the anti-RSV-peptide with liposomes can significantly increase the RSV inhibition when compared with the anti-RSV peptide alone.
LanguageEnglish
Article number37
Number of pages14
JournalBioengineering
Volume5
Issue number2
DOIs
Publication statusPublished - 9 May 2018

Fingerprint

Respiratory Syncytial Viruses
Liposomes
Viruses
Peptides
Fusion reactions
Respiratory Tract Infections
Infection

Keywords

  • liposomes
  • respiratory syncytial virus
  • peptide
  • hydrophilic

Cite this

Joshi, Sameer ; Chaudhari, Atul A. ; Dennis, Vida ; Kirby, Daniel J. ; Perrie, Yvonne ; Singh, Shree Ram . / Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus. In: Bioengineering. 2018 ; Vol. 5, No. 2.
@article{d408b97ca7ce4475aabc5c61195cbb15,
title = "Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus",
abstract = "Although respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infection in infants and adults, effective treatment options remain limited. To circumvent this issue, there is a novel approach, namely, the development of multifunctional liposomes for the delivery of anti RSV-peptides. While most of the peptides that are used for loading with the particulate delivery systems are the penetrating peptides, an alternative approach is the development of liposome-peptide systems, which are loaded with an RSV fusion peptide (RF-482), which has been designed to inhibit the RSV fusion and block infection. The results of this work have revealed that the liposomes themselves can serve as potential RSV inhibitors, whilst the anti-RSV-peptide with liposomes can significantly increase the RSV inhibition when compared with the anti-RSV peptide alone.",
keywords = "liposomes, respiratory syncytial virus, peptide, hydrophilic",
author = "Sameer Joshi and Chaudhari, {Atul A.} and Vida Dennis and Kirby, {Daniel J.} and Yvonne Perrie and Singh, {Shree Ram}",
year = "2018",
month = "5",
day = "9",
doi = "10.3390/bioengineering5020037",
language = "English",
volume = "5",
journal = "Bioengineering",
issn = "2306-5354",
number = "2",

}

Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus. / Joshi, Sameer; Chaudhari, Atul A.; Dennis, Vida; Kirby, Daniel J.; Perrie, Yvonne; Singh, Shree Ram .

In: Bioengineering, Vol. 5, No. 2, 37, 09.05.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus

AU - Joshi, Sameer

AU - Chaudhari, Atul A.

AU - Dennis, Vida

AU - Kirby, Daniel J.

AU - Perrie, Yvonne

AU - Singh, Shree Ram

PY - 2018/5/9

Y1 - 2018/5/9

N2 - Although respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infection in infants and adults, effective treatment options remain limited. To circumvent this issue, there is a novel approach, namely, the development of multifunctional liposomes for the delivery of anti RSV-peptides. While most of the peptides that are used for loading with the particulate delivery systems are the penetrating peptides, an alternative approach is the development of liposome-peptide systems, which are loaded with an RSV fusion peptide (RF-482), which has been designed to inhibit the RSV fusion and block infection. The results of this work have revealed that the liposomes themselves can serve as potential RSV inhibitors, whilst the anti-RSV-peptide with liposomes can significantly increase the RSV inhibition when compared with the anti-RSV peptide alone.

AB - Although respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infection in infants and adults, effective treatment options remain limited. To circumvent this issue, there is a novel approach, namely, the development of multifunctional liposomes for the delivery of anti RSV-peptides. While most of the peptides that are used for loading with the particulate delivery systems are the penetrating peptides, an alternative approach is the development of liposome-peptide systems, which are loaded with an RSV fusion peptide (RF-482), which has been designed to inhibit the RSV fusion and block infection. The results of this work have revealed that the liposomes themselves can serve as potential RSV inhibitors, whilst the anti-RSV-peptide with liposomes can significantly increase the RSV inhibition when compared with the anti-RSV peptide alone.

KW - liposomes

KW - respiratory syncytial virus

KW - peptide

KW - hydrophilic

UR - http://www.mdpi.com/journal/bioengineering

U2 - 10.3390/bioengineering5020037

DO - 10.3390/bioengineering5020037

M3 - Article

VL - 5

JO - Bioengineering

T2 - Bioengineering

JF - Bioengineering

SN - 2306-5354

IS - 2

M1 - 37

ER -